


Healthcare News Roundup: Neuro
HSMN NewsFeed - 19 Dec 2017
Zimmer Biomet Announces Appointment of Bryan C. Hanson as President and Chief Executive Officer
Zimmer Biomet Announces Appointment of Bryan C. Hanson as President and Chief Executive Officer
HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
HSMN NewsFeed - 18 Dec 2017
Respicardia Closes $58.5 Million In Financing To Treat Central Sleep Apnea
Respicardia Closes $58.5 Million In Financing To Treat Central Sleep Apnea
HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
HSMN NewsFeed - 7 Dec 2017
Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
HSMN NewsFeed - 7 Dec 2017
Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements
Bioness StimRouter(R) Neuromodulation System Eligible for Increased Medicare Reimbursements
HSMN NewsFeed - 7 Dec 2017
Camber Spine Announces FDA Clearance Of Spira(TM)-C Open Matrix Cervical Interbody
Camber Spine Announces FDA Clearance Of Spira(TM)-C Open Matrix Cervical Interbody
HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
HSMN NewsFeed - 9 Nov 2017
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
HSMN NewsFeed - 2 Nov 2017
BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer
BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer
HSMN NewsFeed - 2 Nov 2017
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
